Literature DB >> 17442669

Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/autophagin-3.

Guillermo Mariño1, Natalia Salvador-Montoliu, Antonio Fueyo, Erwin Knecht, Noboru Mizushima, Carlos López-Otín.   

Abstract

Atg4C/autophagin-3 is a member of a family of cysteine proteinases proposed to be involved in the processing and delipidation of the mammalian orthologues of yeast Atg8, an essential component of an ubiquitin-like modification system required for execution of autophagy. To date, the in vivo role of the different members of this family of proteinases remains unclear. To gain further insights into the functional relevance of Atg4 orthologues, we have generated mutant mice deficient in Atg4C/autophagin-3. These mice are viable and fertile and do not display any obvious abnormalities, indicating that they are able to develop the autophagic response required during the early neonatal period. However, Atg4C-/--starved mice show a decreased autophagic activity in the diaphragm as assessed by immunoblotting studies and by fluorescence microscopic analysis of samples from Atg4C-/- GFP-LC3 transgenic mice. In addition, animals deficient in Atg4C show an increased susceptibility to develop fibrosarcomas induced by chemical carcinogens. Based on these results, we propose that Atg4C is not essential for autophagy development under normal conditions but is required for a proper autophagic response under stressful conditions such as prolonged starvation. We also propose that this enzyme could play an in vivo role in events associated with tumor progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17442669     DOI: 10.1074/jbc.M701194200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  184 in total

Review 1.  Autophagy and cancer.

Authors:  Li Yen Mah; Kevin M Ryan
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-01-01       Impact factor: 10.005

Review 2.  Hemopressin and other bioactive peptides from cytosolic proteins: are these non-classical neuropeptides?

Authors:  Julia S Gelman; Lloyd D Fricker
Journal:  AAPS J       Date:  2010-04-10       Impact factor: 4.009

Review 3.  Deconvoluting the complexity of microRNAs in autophagy to improve potential cancer therapy.

Authors:  Dahong Yao; Yingnan Jiang; Suyu Gao; Lei Shang; Yuqian Zhao; Jian Huang; Jinhui Wang; Shilin Yang; Lixia Chen
Journal:  Cell Prolif       Date:  2016-07-20       Impact factor: 6.831

Review 4.  Photoreceptor cell death and rescue in retinal detachment and degenerations.

Authors:  Yusuke Murakami; Shoji Notomi; Toshio Hisatomi; Toru Nakazawa; Tatsuro Ishibashi; Joan W Miller; Demetrios G Vavvas
Journal:  Prog Retin Eye Res       Date:  2013-08-28       Impact factor: 21.198

Review 5.  Amino acid management in cancer.

Authors:  Zhi-Yang Tsun; Richard Possemato
Journal:  Semin Cell Dev Biol       Date:  2015-08-12       Impact factor: 7.727

Review 6.  Autophagy and cancer cell metabolism.

Authors:  Fred Lozy; Vassiliki Karantza
Journal:  Semin Cell Dev Biol       Date:  2012-01-18       Impact factor: 7.727

7.  A PINK1-mediated mitophagy pathway decides the fate of tumors-to be benign or malignant?

Authors:  Hui Qian; Xiaojuan Chao; Wen-Xing Ding
Journal:  Autophagy       Date:  2018-02-21       Impact factor: 16.016

8.  AU4S: a novel synthetic peptide to measure the activity of ATG4 in living cells.

Authors:  Zhenhong Ni; Yi Gong; Xufang Dai; Wen Ding; Bin Wang; Haiyan Gong; Liyan Qin; Panke Cheng; Song Li; Jiqin Lian; Fengtian He
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

9.  DJ-1/PARK7 is an important mediator of hypoxia-induced cellular responses.

Authors:  Sophie Vasseur; Samia Afzal; Joël Tardivel-Lacombe; David S Park; Juan Lucio Iovanna; Tak Wah Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-14       Impact factor: 11.205

Review 10.  The cell biology of autophagy in metazoans: a developing story.

Authors:  Alicia Meléndez; Thomas P Neufeld
Journal:  Development       Date:  2008-08       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.